IBIO logo

IBIO
iBio Inc

92,984
Mkt Cap
$84.63M
Volume
1.18M
52W High
$5.31
52W Low
$0.5562
PE Ratio
-2.44
IBIO Fundamentals
Price
$2.45
Prev Close
$2.49
Open
$2.53
50D MA
$2.37
Beta
1.35
Avg. Volume
1.23M
EPS (Annual)
-$1.75
P/B
1.30
Rev/Employee
$20,000.00
$2.94
Loading...
Loading...
News
all
press releases
iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of "Buy" by Analysts
Shares of iBio, Inc. (NASDAQ:IBIO - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are covering the company, MarketBeat.com reports. One analyst has...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
iBio (NYSE:IBIO) Now Covered by Analysts at JonesTrading
JonesTrading started coverage on shares of iBio in a report on Tuesday. They set a "buy" rating and a $7.00 price target for the company...
MarketBeat·12d ago
News Placeholder
iBio (NASDAQ:IBIO) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded iBio from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·15d ago
News Placeholder
iBio (NYSEMKT:IBIO) Stock Price Up 2.9% - Should You Buy?
iBio (NYSEMKT:IBIO) Shares Up 2.9% - Here's Why...
MarketBeat·18d ago
News Placeholder
Brookline Cap M Weighs in on iBio's Q3 Earnings (NYSE:IBIO)
iBio, Inc. (NYSE:IBIO - Free Report) - Stock analysts at Brookline Cap M raised their Q3 2026 earnings estimates for shares of iBio in a report issued on Wednesday, February 11th. Brookline Cap M...
MarketBeat·27d ago
News Placeholder
iBio (NASDAQ:IBIO) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen cut shares of iBio from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·29d ago
News Placeholder
iBio Earnings Review: Q2 Summary
read more...
Benzinga·1mo ago
News Placeholder
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
iBio (IBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
iBio (NASDAQ:IBIO) Stock Price Down 3.6% - Here's Why
iBio (NASDAQ:IBIO) Trading Down 3.6% - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest IBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.